CORRESP Filing
Rani Therapeutics Holdings, Inc.
Date: Dec. 1, 2025 · CIK: 0001856725 · Accession: 0001193125-25-303863
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291394
Letter
RE: Rani Therapeutics Holdings, Inc.
RANI THERAPEUTICS HOLDINGS, INC. 2051 Ringwood Avenue San Jose, California 95131 December 1, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Registration Statement on Form S-3
File No. 333-291394 Ladies and Gentlemen: Rani Therapeutics Holdings, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on December 3, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059.
Very truly yours,
RANI THERAPEUTICS HOLDINGS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP RANI THERAPEUTICS HOLDINGS, INC. 2051 Ringwood Avenue San Jose, California 95131 December 1, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Rani Therapeutics Holdings, Inc. Registration Statement on Form S-3 File No. 333-291394 Ladies and Gentlemen: Rani Therapeutics Holdings, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on December 3, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059. Very truly yours, RANI THERAPEUTICS HOLDINGS, INC. By: /s/ Svai Sanford Name: Svai Sanford Title: Chief Financial Officer cc: Josh Seidenfeld, Cooley LLP John T. McKenna, Cooley LLP